Flu triple action powder - analgesic and antipyretic decongestant - 10 sachets

Product Description

Vicks

Sachets

Composition:

One sachet contains: 500 mg of paracetamol 200 mg of guaifenesin 10 mg of phenylephrine hydrochloride Excipients: Sucrose 2000 mg Aspartame 6 mg Sodium 157 mg For the full list of excipients, see section 6.1.

Excipients

Sucrose Citric acid Tartaric acid Sodium cyclamate Sodium citrate Aspartame (E951) Acesulfame potassium (E950) Menthol powder Lemon flavouring Lemon juice flavouring Quinoline yellow (E104)

Therapeutic indications

Short-term symptomatic treatment of mild to moderate pain, fever, nasal congestion with expectorant effect in case of productive cough, associated with colds, chills and flu.

Contraindications

Hypersensitivity to paracetamol, guaifenesin, phenylephrine hydrochloride or to any of the excipients. Hepatic impairment or severe renal impairment. Hypertension. Hyperthyroidism. Diabetes. Cardiac disease. Closed-angle glaucoma. Porphyria. Use in patients taking tricyclic antidepressants. Use in patients taking, or who have taken in the previous 2 weeks, monoamine oxidase inhibitors (MAOIs). Use in patients taking beta-blockers. Use in patients taking other sympathomimetic drugs. Children under 12 years of age.

Dosage

Dissolve the contents of one sachet in a medium-sized cup and add hot, not boiling, water (approximately 250 ml). Allow to cool to a drinkable temperature. Adults and children aged 12 years and over: one sachet. Repeat every four hours as directed, without exceeding four doses (sachets) in a 24-hour period. Do not administer to children under 12 years of age without medical advice. Do not administer to patients with hepatic impairment or severe renal impairment (see section 4.3). Consult your doctor if symptoms persist for more than 3 days.

Warnings and precautions

Prolonged use of the product is not recommended. Patients should be advised not to take other products containing paracetamol or containing the same active ingredients as this preparation. Patients should also be advised to avoid the concomitant use of alcohol, other decongestant products, or cough or cold products. The doctor or pharmacist is required to ensure that preparations containing sympathomimetics are not administered simultaneously through multiple routes, i.e., orally and topically (nasal, auricular, and ocular preparations). This medicine should only be recommended in the presence of all symptoms (pain and/or fever, nasal congestion, and bronchial cough). The risks associated with overdose are greater in patients with non-cirrhotic alcoholic liver disease. Use with caution in patients taking digitalis, beta-adrenergic blockers, methyldopa, or other antihypertensive agents (see section 4.5). Use with caution in patients with prostatic hypertrophy as they may be subject to urinary retention. Products containing sympathomimetics should be used with great caution in patients taking phenothiazines. Use in patients with Raynaud's phenomenon. Consult your doctor before use in case of persistent or chronic cough such as that caused by smoking, asthma, chronic bronchitis, or emphysema. Contains sucrose. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase-isomaltase insufficiency should not take this medicine. Contains 157 mg sodium per dose. To be taken into consideration by patients with reduced kidney function or on a controlled sodium diet. Contains aspartame (E951). This medicine contains a source of phenylalanine. May be harmful if you have phenylketonuria.